NCT03611088

Brief Summary

Growing evidences indicates that the Kangaroo Mother Method is associated with health benefits for the child and her mother. Improvements have been found in physiological parameters of the preterm infants assisted by the method. Some of them are the reduction of the heart rate and respiratory, as well as the increase of the body temperature and of the arterial saturation of oxygen. More recently, it has been observed that children submitted to the method present an improvement in muscle tone, by the increase in the electromyographic activity of the biceps brachii and hamstrings. These physiological changes can result in benefits for the child, with a positive influence on their development. It is well established that the preterm newborn has an important circulatory vulnerability, since the transition from fetal life to extrauterine life is a complex process in which the major changes are concentrated in the cardiovascular system and occur during the first Hours after birth accompanied by important consequences in physiological parameters, such as systemic vascular resistance, heart rate and blood flow in the organs. Therefore, global hemodynamic parameters have been studied in premature infants, especially after some intervention. It is worth noting, however, that these global parameters such as blood pressure, heart rate and arterial oxygen saturation do not reflect the existence of adequate tissue oxygenation, since they are macrocirculatory and non-microcirculatory parameters. In order to obtain reliable signals on tissue oxygenation, it is essential to study the microcirculation. To further explore the effects that Kangaroo Position promotes on the physiological aspects of the newborn, especially on hemodynamic parameters, we consider it important to study aspects that may, in fact, represent an adequate tissue oxygenation. Therefore, the objective of this study is to evaluate the effect of Kangaroo Position in the electromyographic activity and on hemodynamic parameters, by means of microcirculation/macrocirculation measurements.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

July 16, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

August 2, 2018

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2018

Completed
Last Updated

August 14, 2018

Status Verified

August 1, 2018

Enrollment Period

2 months

First QC Date

July 16, 2018

Last Update Submit

August 13, 2018

Conditions

Keywords

Child DevelopmentKangaroo Mother Care MethodElectromyographyMicrocirculationPremature

Outcome Measures

Primary Outcomes (8)

  • Electromyographic activity

    Represented by the recording of the myoelectric signal captured through the electromyographic analysis, analyzed in Root Mean Square (RMS) and measured in microvolts.

    1 minute

  • oxygen artery saturation

    Represented by the macrocirculation variables

    1 minute

  • heart rate

    Represented by the macrocirculation variables

    1 minute

  • tissue oxygen saturation

    Represented by the microcirculation variables

    1 minute

  • oxygenated hemoglobin concentration

    Represented by the microcirculation variables

    1 minute

  • deoxygenated hemoglobin concentration

    Represented by the microcirculation variables

    1 minute

  • tissue temperature

    Represented by the microcirculation variables

    1 minute

  • oxygen flow

    Represented by the microcirculation variables

    1 minute

Study Arms (2)

Newborns submitted to Kangaroo Position.

EXPERIMENTAL
Other: Kangaroo Position.

Newborns not submitted to Kangaroo Position.

NO INTERVENTION

Interventions

The kangaroo position - the newborn is positioned in the adult's breasts, face down, should be dressed in light clothes and wrapped in a flexible cloth.

Newborns submitted to Kangaroo Position.

Eligibility Criteria

Age27 Weeks - 37 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Preterm newborns with gestational ages older or equal than 27 and less than 37 completed weeks of gestation (Ballard Method)
  • Preterm newborns hospitalized at Instituto de Medicina Integral Prof. Fernando Figueira (IMIP) with a corrected age less than 37 weeks at the moment of the evaluation
  • Preterm newborns who were not submitted to the Kangaroo Position previously.

You may not qualify if:

  • Apgar less than 7 in the 5''
  • Previous history of intracranial hemorrhage (diagnosed by ultrasonography and recorded in the medical record)
  • Previous convulsion history
  • Congenital infection
  • Infections of the central nervous system (meningitis or encephalitis)
  • Malformations in the central nervous system
  • Congenital cardiopaths
  • Trauma during delivery
  • Gastroesophageal reflux disease
  • Phototherapy and anemia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rafael Moura Miranda

Recife, Pernambuco, 51110380, Brazil

Location

Related Publications (1)

  • Miranda RM, Cabral Filho JE, Diniz KT, Clough GF, Alves JGB, Lima GMS, Figueredo NPDS, Franca AA, Luna JTB. Effect of Kangaroo Position on microcirculation of preterm newborns: a controlled randomized clinical trial. J Pediatr (Rio J). 2022 Mar-Apr;98(2):196-203. doi: 10.1016/j.jped.2021.05.012. Epub 2021 Aug 26.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 16, 2018

First Posted

August 2, 2018

Study Start

July 16, 2018

Primary Completion

September 1, 2018

Study Completion

October 31, 2018

Last Updated

August 14, 2018

Record last verified: 2018-08

Locations